Dental Implants Market Size Worth $9.0 Billion By 2027

The global dental implants market size is expected to reach a value of USD 9.0 billion by 2027, registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for tooth replacement has provided good growth potential to the market. Increasing number of dental injuries owing to road accidents and sports injuries are some of the major factors boosting the demand.

With growing aesthetic awareness, people are exploring more treatment options, which is leading to the growth of the market. For instance, as per the American Academy of Cosmetic Dentistry data, more than 95% of individuals across the globe believe that their smile is a vital social asset and nearly 84% revealed to be under an increased pressure to perfect their smile, thus increasing the product demand.

Dental implants are considered as the only restorative technique that preserves and stimulates natural bone. Owing to the growing number of edentulous people, the demand for prosthetics is increasing, which is expected to be one of the major impact rendering drivers for the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/dental-implants-market

Further key findings from the study suggest:

The titanium implant type segment held the largest market share in 2019 due to its wide applications, durability, and cost-effectiveness
Zirconia implants are anticipated to witness a lucrative growth rate over the forecast period due to better flexural strength, improved aesthetic appearance, and less corrosiveness as compared to titanium
Europe dominated the market in 2019 owing to the large geriatric population and the presence of established market players
Asia Pacific region is anticipated to grow at a rapid pace over the forecast period owing to increasing disposable income, growing geriatric population and increasing awareness regarding oral hygiene and treatment options
Some of the key companies in the dental implants market are Nobel Biocare Services AG; BioHorizons IPH, Inc.; Straumann AG; Zimmer Biomet Holdings, Inc.; DENTSPLY Sirona; OSSTEM IMPLANT; Bicon, LLC; Leader Italy; Anthogyr SAS; KYOCERA Medical Corporation; DENTIUM Co., Ltd.; T-Plus Implant Tech. Co.; and DENTIS

Pacemaker Market Size Worth $5.8 Billion By 2027

The global pacemaker market size is anticipated to reach USD 5.8 billion by 2027, expanding at a CAGR of 2.9%, as per the new report by Grand View Research, Inc. The increasing prevalence of cardiovascular diseases is a key growth driver for the market. As per the CDC, in 2017, CVDs accounted for about 800,000 deaths in the U.S alone. Moreover, coronary heart disease accounts for the highest number of deaths, followed by stroke and heart failure.

As per the British Heart Foundation Centre in 2018, nearly 7.4 million individuals are living with circulatory and heart diseases in the UK. More than 43,000 individual under 75 years of age dies due to cardiac diseases every year in the UK. To curb the rising prevalence of CVDs is government bodies and key market players are channelizing revenues to offer a potential treatment. This is anticipated by the influx of advanced products in this market space.

As per the CDC, 2020, more than 15.0% of U.S. adults are physically inactive that shows the prevalence of adult physical inactivity. Technological developments are quickly renovating the market. Key players are focusing on expanding their current portfolio such as in January 2020, BIOTRONIK launched an injectable cardiac monitor, BIOMONITOR III in Japan. It is intended to measure irregular heart rhythms with increased clarity. The injectable cardiac monitor also documents the unexplained syncope. Moreover, in January 2019, Medtronic launched MyCareLink Heart (TM)-a mobile app for communicating directly with patients via smartphones.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/pacemaker-market

Further key findings from the report suggest:

MRI compatible pacemakers is the fastest-growing segment from 2020 to 2027 owing toa higher patient preference rate as 75% of the patients with pacemakers are likely to get MRI during their lifetimes
Atrial Fibrillation held the largest market share in 2019 owing to the heightened prevalence of growing with age. As per the National Center for Biotechnology Information, 2020, nearly 6 to 12 million people globally are expected to suffer from atrial fibrillation in the US alone by 2050
The biventricular chamber product segment is expected to be the fastest-growing segment from 2020 to 2027. The device is also is known as Cardiac Resynchronization Therapy (CRT) device. An increase in the prevalence of heart failure is one of the major factors driving the growth of the segment
Key companies are adopting new strategies to attain a competitive edge. Product development, collaborations, partnerships, mergers and acquisitions, and regional expansion are few of them.

Tissue Diagnostics Market Worth $6.6 Billion By 2027

The global tissue diagnostics market size is anticipated to reach USD 6.6 billion by 2027, growing at a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to the lack of skilled pathologists has driven the market. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplement market growth.

The digitalization of tissue diagnostic techniques has resulted in the improvement of workflows and better patient care. Ongoing strategic models taken-up by key companies to enhance the efficiency of diagnostics also drives the market. For instance, in December 2019, Philips collaborated with Paige to provide clinical-grade artificial intelligence-based solutions to pathology laboratories. This enhanced the speed and accuracy of cancer diagnostics in laboratories.

Tissue diagnostic techniques, such as immunohistochemistry (IHC) or in situ hybridization, are used in companion diagnostics (CDx) to determine the quantity of a target analyte present in the sample. Introduction of CDx tests, such as the launch of the VENTANA HER2 Dual ISH CDx

Click the link below:
https://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market

Further key findings from the report suggest:

IHC tests are highly adopted as these tests are specific and helpful in identifying the variations between different types of cancer, resulting in the largest revenue share
A rise in the investments for the development of advanced infrastructure to digitalize images is anticipated to drive the digital pathology segment with the fastest CAGR.
Moreover, an increase in the demand for automated modalities owing to a dearth of skilled pathologists further compliments this growth
A large number of breast cancer cases coupled with a rise in the application of digital image processing techniques on histopathological samples for breast cancer detection contributes to the largest share of breast cancer
Prostate cancer is anticipated to register lucrative growth owing to the extensive ongoing research pertaining to early diagnosis and prevention of this disease
Hospitals dominated the market in terms of revenue share due to the high adoption of tissue diagnostics solutions. These solutions provide accurate results in minimal time than conventional testing procedures
North America accounted for the largest revenue share owing to increasing collaborations between pharmaceutical and biotech firms to expand their product offerings
The requirement of better laboratory management systems, growing demand for novel patient care facilities, and favorable regulatory framework, boost the Asia Pacific market at a lucrative pace
Abbott, QIAGEN, Roche, Siemens, Danaher, Thermo Fisher, and Merck are some key participants operating in the tissue diagnostics market
Key vendors are engaged in novel product developments, partnership, and acquisition models to maintain their revenue share in the market.

Payment Processing Solutions Market Size Worth $98.01 Billion By 2027

The global payment processing solutions market size is expected to reach USD 98.01 billion by 2027, registering a CAGR of 14.5% from 2020 to 2027, according to a new report by Grand View Research, Inc. The market growth can be attributed to the emergence of digital technology and customers’ demand for immediacy of transactions. The customers are looking for faster and convenient money transfer options, thereby driving the adoption of payment processing solutions.

Technologies such as the Internet of Things (IoT), machine learning, and Artificial Intelligence (AI) are all finding their way into numerous industries in order to streamline and simplify process of transactions. Machine learning can automatically recognize patterns across large volumes of transactions to quickly identify fraudulent activities. Moreover, artificial intelligence offers the ability to personalize the customer experience and enhance customer service.

Machine learning integrated processing solutions are used for the authorization of money transfer patterns and transaction monitoring. Machine learning tools enable FinTech companies to accurately process this data to decrease costs, meet customer needs, and better allocate resources. Furthermore, these solutions allow businesses to provide better customer services to their customers.

Service providers are focusing on leveraging IoT into their payment processing solutions. They enable money transfer through connected voice assistants and smart TVs. These services are allowing customers to pay when, where, and how they want to pay.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/payment-processing-solutions-market

Further key findings from the report suggest:

Growing popularity of smartphones and technological innovations are anticipated to boost the usage of e-wallets across the globe
As retailers are focusing on diversifying their business operations, they are increasingly embracing wireless and mobile processing technologies for transaction processes. This, in turn, is expected to fuel the adoption of solutions for transaction processing in the retail end-use segment
Increasing e-commerce sales, coupled with growing internet penetration across the region, is expected to fuel the market growth in Asia Pacific over the forecast period
Key vendors in the market include SecurePay; PayU Group; PayPal Holdings, Inc.; Authorize.Net; and Alipay.

Transportation Analytics Market Size Worth 21.8 Billion By 2027

The global transportation analytics market size is expected to reach USD 21.8billion by 2027, registering at a CAGR of 15.6% from 2020 to 2027, according to a new study conducted by Grand View Research, Inc. Increasing expenditure of governments in transportation sector across the world and the growth of smart cities vis-à-vis urbanization are the major driving forces fostering the market growth. Moreover, consumerization of big data, advancements in analytics technology owing to artificial intelligence and machine learning will aid the utility of analytics in the transportation industry. Besides, acquisition of analytics startups, mergers and collaboration, and research and development investment in technology enhancement of analytics by major industry players will boost the market growth.

As per the published report by Transport Research Centre of Czech Republic, in 2018 there are around 500 million surveillance cameras across the world, generating 15 billion gigabytes of data per week. This number will double every two years, which will be stored and analyzed for improving and streamlining the public transport situation. The potential of data collection and its analysis will also be harnessed through growing application of intelligent transport systems across the world. Moreover, the data collected from the sensing platforms such as intra vehicular and urban sensing platform will help in achieving the primary aim of Intelligent Transport Systems (ITS) such as access and mobility, economic development, and environmental sustainability. All the precedent factors will help boost the market growth over the forecast period.

As per automobile industry estimates, in 2015 there were around 1.3 billion vehicles plying on the road worldwide and with growing economy in developing regions, the number is expected to rise over 2 billion by 2040. The development of new roads and bypasses will not suffice the ever increasing traffic level loads in urban areas across the globe. However, with the combination of new transport analytics solutions and communications technology with the aid of Artificial Intelligence (AI), large amount of traffic data can be analyzed in real time to cope the growing number of vehicles. Such developments across the transportation and communication sector will propel growth of the market for transportation analytics solutions over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/transportation-analytics-market

Further key findings from the study suggest:

The prescriptive type of transportation analytics is likely to grow at rapid rate over the forecast period. Emergence of advanced technologies such as AI and ML, and advent of IoT is likely to boost the segment growth. Among major vendors, Oracle’s Analytics cloud platform offers predictive analytics software within the platform, which helps developers to mine various data types, destroy the movement of data, and deliver actionable insights
The cloud deployment was the most preferred way for deployment of the analytics in 2019 and is anticipated to grow rapidly over the next eight years. Growth in cloud computing technology and its services such as SaaS, PaaS, and IaaS will foster the segment growth
The planning and maintenance management application is anticipated to be the fastest growing segment over the forecast period. Reduction in downtime, monitoring assets for anomalies, cost effective servicing and repairs, trends and forecasting events through analytics are some of the major factors that are likely to drive the segment growth
Asia Pacific is expected to expand at the highest CAGR from 2019 to 2025 owing to smart transportation and traffic management initiativesundertaken by countries such asJapan, China, South Korea, Australia, and Taiwan. For instance, China’s 5 year plan for modern comprehensive transportation system will include SMART urban transportation management, integrated mobile payment solutions, mobile apps, shared mobility, and the use of big data in transport
Key market players include Cellint Corporation; Alteryx Inc.; Oracle Corporation; Inrix Corporation; IBM Corporation; SmartDrive Systems Inc.; Cubic Corporation; Sisense Inc.; Hitachi Ltd.; and Omnitracs LLC

Digital Workplace Market Worth $54.2 Billion By 2027

The global digital workplace market size is expected to reach USD 54.2 billion by 2027, expanding at a CAGR of 11.3% from 2020 to 2027, according to a new report by Grand View Research, Inc. The availability of new software and tools, demand for remote working, and focus on improved employee experience are driving the adoption of the digital workplace. Advancements in workplace technologies and Software as a Service (SaaS) have led to the implementation of cloud systems, thus, driving the overall market. The shift in the generational workforce has led to the adoption of digitalization in the workplace. The utilization of various gadgets such as smartphones, laptops, and tablets has provided ease to the mid-aged generation.

Digital workplace aligns the employees, technologies, and businesses in such a way that they improve operational efficiency and meets various goals set by organizations across verticals such as IT and telecommunication, consumer goods, retail, manufacturing, and pharmaceuticals. The smooth integration of digital workplace tools within the workspace is often easily achieved at organizations having higher digital literacy. With the growing importance of customer satisfaction and their experience at priority, companies also need to focus on employee experience as they act as the key driver in exhibiting the organizational capabilities. Furthermore, the adoption of digital workplace solutions and services enables not only retaining employees but also contributes in attracting a talented workforce. Moreover, on-going technological advancement, such as the use of AI and machine learning to optimize the business performance, and its collaboration with the workforce, would drive the market over the forecast period.

Companies such as DXC Technology Company, IBM, HCL Technologies Limited, Atos SE, NTT Data Corporation, Citrix Systems, Inc.; Tata Consultancy Services Limited, Wipro Limited, among others, are the key players operating in the market. DXC Technology Company is one of the prominent providers that has robust capabilities and a wide global presence to deliver workplace solutions. Atos’ acquisition of Syntel represents a significant boost in its abilities to deliver digital workplace transformation services in all the regions. Atos can leverage Syntel’s suite of proprietary solutions that use cloud, social media, analytics, mobile, and IoT to deliver digital transformation.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/digital-workplace-market

Further key findings from the report suggest:

The small and medium enterprises segment is expected to grow at the highest rate of 11.8% over the forecast period. Increasing BYOD trends, remote working culture in small, medium, and large enterprises in emerging economies are expected to drive the market over the forecast period
IT and Telecommunication segment held the largest share of more than 34.0% of the overall market in 2019
North America held the largest market size valued at USD 7.3 billion in 2019, whereas the Asia Pacific region is poised to witness the highest CAGR of 12.5% over the forecast period
Key players including DXC Technology Company; IBM; HCL Technologies Limited; Atos SE; NTT Data Corporation; Citrix Systems, Inc.; Tata Consultancy Services Limited; Wipro Limited accounted for a majority share of the overall market in 2019.

Pulmonary Arterial Hypertension Market Size Worth $9.8 Billion By 2027

The global pulmonary arterial hypertension market size is expected to reach USD 9.8 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 5.6% over the forecast period. Increasing prevalence rates of pulmonary arterial hypertension (PAH) and government support for the development of orphan drugs drive the market growth.

The cases of PAH are rising in the range of 100,000 to 200,000 per year. However, in the past few years, the occurrence of PAH has been increasing due to risk factors such as alcohol/tobacco consumption, HIV, sedentary lifestyle, smoking, and other idiopathic conditions. Moreover, the geriatric population is more prone to PAH and associated diseases owing to reduced immune function. According to the National Council on Aging (NCOA), about 80 percent of the population aged 65 and above have at least one chronic condition such as high cholesterol, diabetes, heart or kidney disease, or chronic obstructive pulmonary disease.

Government initiatives such as the Rare Disease Act 2002 and The Orphan Drug Act (ODA) 1983, are also anticipated to support the market for treatment drugs for PAH. These acts play a significant role in promoting the ethical usage and distribution of orphan drugs. The development of orphan drugs is promoted by the National Organization of Rare Disorders.

Robust drug pipeline and new product combinations awaiting approval or launch are anticipated to increase the PAH market competitiveness over the forecast period. In September 2019, Acceleron Pharma, a leading biopharmaceutical company, received FDA orphan drug designation for sotatercept for the treatment of pulmonary arterial hypertension.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/pulmonary-arterial-hypertension-market

Further key findings from the report suggest:

Prostacyclin and its analogs for treating PAH are projected to show lucrative growth over the forecast period. The sales of these drugs are anticipated to increase due to the growing use of oral prostacyclin agents
North America dominated the PAH market with a share of over 55.0% in 2019. This is attributed to the well-established infrastructure for the development and distribution of high-quality therapies and the availability of reimbursement for PAH therapies
Asia Pacific is estimated to register the highest CAGR of more than 6.0% over the forecast period due to its huge population base, rapid economic development, and improving healthcare system. Moreover, the high burden of diseases such as HIV in the region contribute to the development of PAH
The major players in the pulmonary arterial hypertension market that offer treatment solutions for PAH include GlaxoSmithKline plc; Johnson & Johnson Services, Inc. (Actelion Pharmaceuticals, Ltd.); United Therapeutics Corporation; Pfizer, Inc.; and Gilead Sciences, Inc. The market is consolidated and competitive in nature. The players enjoy the benefit of high entry barriers to other firms due to high price interdependency

Next Generation Sequencing Market Size Worth $23.7 Billion By 2027

The global next generation sequencing market size is expected to reach USD 23.7 billion by 2027, expanding at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Numerous advantages offered by high throughput sequencing over other genetic technologies such as sanger-seq and microarray is one of the key driving forces of the market for Next Generation Sequencing (NGS). Furthermore, increasing availability of low input DNA sampling methods that decrease the overall operational costs is anticipated to accelerate the use of next generation sequencing across various research and clinical applications.

Technology offered by New England Biolabs that employs magnetic beads in the template assembly process is anticipated to significantly improve the sample preparation protocols for next generation sequencing. Furthermore, recent technological advancements such as the use of Laboratory Information Management System (LIMS) for genome library automation allow next generation sequencing in a single day at a reasonable cost. These advancements are anticipated to proliferate the number of users of next generation sequencing over the forecast period.

This technology has captured the attention of several companies and investors operating across various domains including basic research, drug discovery and development, reproductive health, and consumer genomics. In addition, the plummeting cost and the added value of next generation sequencing data over conventional ones is anticipated to positively impact the diversification of this technology in other clinical areas, resulting into a lucrative revenue growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market

Further key findings from the report suggest:

In 2019, oncology was estimated as the application with the largest revenue share in the market for next generation sequencing
This can be attributed to the fact that the technology has been largely adopted to decipher the link between cancer and genetics
Moreover, NGS-based genetic testing for cancer predisposition can significantly improve the health outcome and reduce the mortality rate, thereby driving adoption in this segment
The targeted sequencing segment has dominated the revenue share owing to its various benefits over the whole genome segment with respect to the depth of coverage and multiplexing capacities
Significant price drop in sequencing the whole genome is anticipated to drive the segment at a lucrative growth rate
Based on workflow, sequencing accounted for the major revenue share in 2019 in the market for next generation sequencing and is anticipated to maintain its dominance over the forecast period
Being a key step, the end-users are making major investments in the seq-step, compared to sample preparation and data analysis
Moreover, the key developers are engaged in introducing new seq-platforms with enhanced capabilities and efficiency. These factors have led the segment in terms of revenue over the past years
Academic research entities are the largest end-users in terms of revenue generation owing to the high penetration of seq-technology in research activities
On the other hand, this technology is making continued growth in clinical research and within clinical settings
A substantial number of researchers are engaged in conducting translational research to accelerate the adoption of seq-technology in clinical diagnostics
North America accounted for the maximum revenue share owing to the presence of integrated platform base in U.S.
Presence of Illumina, the major player of next generation sequencing market for U.S. is another major factor that has driven the revenue share of this region in the past years
Asia Pacific is projected to mark fastest growth owing to the increase in number of domestic developers in China coupled with the expansion of molecular diagnostics area
Some major participants in the market for next generation sequencing are Illumina Inc.; F Hoffman-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; and BGI
The companies are collaborating with diagnostic players to extend the use of their platforms in clinical settings
For instance, Illumina has partnered with China’s KingMed Diagnostics for use of its platform in oncology and hereditary disease testing.

MRI Market Size Worth $8.18 Billion By 2027

The global magnetic resonance imaging market size is expected to reach USD 8.18 billion by 2027, registering a revenue-based CAGR of 5.9% during the forecast period, according to Grand View Research, Inc. Rising prevalence of chronic diseases coupled with increasing demand for early diagnostic techniques is projected to drive the growth. In addition, growing adoption of less invasive diagnostic procedures is contributing to the magnetic resonance imaging (MRI) market growth. Moreover, increasing number of clinical trials to understand the effectiveness and efficiency of MRI machines in various clinical applications is expected to boost the growth.

End-users, such as research institutes and universities are frequently studying the efficiency of MRI devices with high field strength such as 7T, 10T, and 10.5T. Growing number of research studies will help unlock the potential usage and advantages of high field MRI machines for various preclinical as well as clinical applications. Currently, 7T MRI machines are only effective in brain and knee imaging, largely due to the absence of advance coil required for these high field machines. Therefore, the development of advance coils to expand the application of 7T MRI machines is expected to propel the growth during the forecast period.

Key market players are adopting various strategies, such as mergers and acquisitions, collaborations, and partnerships to gain competitive edge. For instance, Aurora Imaging Technology entered into a distribution agreement with Sumec Group Corporation. Under this distribution agreement, the latter will distribute MRI portfolio of Aurora Imaging Technology in China. This in turn is helping both the companies in geographical expansion.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/magnetic-resonance-imaging-market

Further key findings from the report suggest:

Open system is anticipated to be the fastest growing segment during the forecast period due to its efficiency to accommodate patients of all sizes without them feeling claustrophobic
Magnetic resonance imaging (MRI) market for neurological and brain disorders held the dominant market share in 2019, largely due to high prevalence of neurological conditions and demand for less invasive diagnostic procedure
The high field MRI segment is expected to experience fastest growth over the forecast period, largely due to efficiency of the field strength to provide detailed diagnostic images
Ambulatory Surgical Centers (ASC) are expected to exhibit the fastest CAGR during the forecast period. Government initiatives to improve primary care is one of the major factor impacting the growth
In 2019, North America dominated the global MRI market in terms of revenue, owing to continuous research activities and high adoption of advanced techniques
Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period, largely due to a rise in clinical studies for high field MRI machines

Digital Pathology Market Worth $1.86 Billion By 2027

The global digital pathology market size is expected to reach USD 1.86 billion by 2027, registering a CAGR of 11.8% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive the market growth. Growing economic stability and awareness pertaining to the benefits of using Computer-Aided Diagnostics (CAD) is further contributing to the growth.

Technological advancements, such as digital imaging, computerization, robotic light microscopy, and multiple fiber optic communications are some of the key factors driving the adoption of digital pathology. In addition, the introduction of cloud-based technology enabling storage of digital slides coupled with secure access to pathologists is expected to serve as a potential growth driver for the market.

Digital pathology has an important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel the adoption of the technology over the forecast period.

The market is expected to witness intense competition in near future owing to the rising adoption of rigorous strategies by the market players to sustain competition. For instance; whole slide imaging system manufacturers focus on obtaining premarket approval for diagnostic digital systems to capture greater revenue share.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market

Further Key Findings From the Report Suggest:

Devices held the dominant market share in 2019 owing to increased use in academic research
The rising implementation of slide management system in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
The software segment is expected to witness lucrative growth in the near future as the product assists in faster diagnosis and synchronization of patient data, where healthcare professionals can remotely access this information
Digital pathology is increasingly used in academic research owing to various benefits, such as cost-effectiveness and rapid results
The disease diagnosis segment is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cancer and demand for noble diagnosis techniques
The availability of unified platforms for workflows in pathology is anticipated to boost the usage of computer-aided imaging technology in academic research, which is anticipated to boost the segment growth
Hospital led the end-use segment in 2019 owing to the increasing adoption of digital pathology
The digital pathology market is expected to remain innovation-led, with frequent acquisitions and strategic alliances. New product development and well-established distribution channels are key to the competitive advantage of leading players
An increasing usage rate of the digital imaging systems to facilitate faster diagnosis, particularly of chronic diseases; the increased uptake of these products serves as the key driver of this market